BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 30422320)

  • 41. Lenalidomide regulates osteocytes fate and related osteoclastogenesis via IL-1β/NF-κB/RANKL signaling.
    Qu X; Mei J; Yu Z; Zhai Z; Qiao H; Dai K
    Biochem Biophys Res Commun; 2018 Jun; 501(2):547-555. PubMed ID: 29746861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lumichrome inhibits osteoclastogenesis and bone resorption through suppressing RANKL-induced NFAT activation and calcium signaling.
    Liu C; Cao Z; Zhang W; Tickner J; Qiu H; Wang C; Chen K; Wang Z; Tan R; Dong S; Xu J
    J Cell Physiol; 2018 Nov; 233(11):8971-8983. PubMed ID: 29904917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIF-1α facilitates osteocyte-mediated osteoclastogenesis by activating JAK2/STAT3 pathway in vitro.
    Zhu J; Tang Y; Wu Q; Ji YC; Feng ZF; Kang FW
    J Cell Physiol; 2019 Nov; 234(11):21182-21192. PubMed ID: 31032948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of low-magnitude, high-frequency vibration on osteocytes in the regulation of osteoclasts.
    Lau E; Al-Dujaili S; Guenther A; Liu D; Wang L; You L
    Bone; 2010 Jun; 46(6):1508-15. PubMed ID: 20211285
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High mobility group box 1 protein regulates osteoclastogenesis through direct actions on osteocytes and osteoclasts in vitro.
    Davis HM; Valdez S; Gomez L; Malicky P; White FA; Subler MA; Windle JJ; Bidwell JP; Bruzzaniti A; Plotkin LI
    J Cell Biochem; 2019 Oct; 120(10):16741-16749. PubMed ID: 31106449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluid Shear Stress Increases Osteocyte and Inhibits Osteoclasts via Downregulating Receptor-Activator of Nuclear Factor κB (RANK)/Osteoprotegerin Expression in Myeloma Microenvironment.
    Wang X; He Y; Tian S; Zhu F; Huang B; Zhang J; Chen Z; Wang H
    Med Sci Monit; 2019 Aug; 25():5961-5968. PubMed ID: 31400110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced osteoclastic resorption and responsiveness to mechanical load in gap junction deficient bone.
    Zhang Y; Paul EM; Sathyendra V; Davison A; Sharkey N; Bronson S; Srinivasan S; Gross TS; Donahue HJ
    PLoS One; 2011; 6(8):e23516. PubMed ID: 21897843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pulsed electromagnetic field stimulates osteoprotegerin and reduces RANKL expression in ovariectomized rats.
    Zhou J; Chen S; Guo H; Xia L; Liu H; Qin Y; He C
    Rheumatol Int; 2013 May; 33(5):1135-41. PubMed ID: 22948539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulsed electromagnetic fields (PEMF) attenuate changes in vertebral bone mass, architecture and strength in ovariectomized mice.
    Lei T; Liang Z; Li F; Tang C; Xie K; Wang P; Dong X; Shan S; Jiang M; Xu Q; Luo E; Shen G
    Bone; 2018 Mar; 108():10-19. PubMed ID: 29229438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluid shear stress improves morphology, cytoskeleton architecture, viability, and regulates cytokine expression in a time-dependent manner in MLO-Y4 cells.
    Yan Z; Wang P; Wu J; Feng X; Cai J; Zhai M; Li J; Liu X; Jiang M; Luo E; Jing D
    Cell Biol Int; 2018 Sep; 42(10):1410-1422. PubMed ID: 30022568
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Supraphysiological loading induces osteocyte-mediated osteoclastogenesis in a novel in vitro model for bone implant loosening.
    Fahlgren A; Bratengeier C; Semeins CM; Klein-Nulend J; Bakker AD
    J Orthop Res; 2018 May; 36(5):1425-1434. PubMed ID: 29068483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucose uptake inhibition decreases expressions of receptor activator of nuclear factor-kappa B ligand (RANKL) and osteocalcin in osteocytic MLO-Y4-A2 cells.
    Takeno A; Kanazawa I; Notsu M; Tanaka KI; Sugimoto T
    Am J Physiol Endocrinol Metab; 2018 Feb; 314(2):E115-E123. PubMed ID: 29018002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parathyroid hormone receptor signaling induces bone resorption in the adult skeleton by directly regulating the RANKL gene in osteocytes.
    Ben-awadh AN; Delgado-Calle J; Tu X; Kuhlenschmidt K; Allen MR; Plotkin LI; Bellido T
    Endocrinology; 2014 Aug; 155(8):2797-809. PubMed ID: 24877630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease.
    Bondar C; Ormazabal M; Crivaro A; Ferreyra-Compagnucci M; Delpino MV; Rozenfeld PA; Mucci JM
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28098793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
    Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
    Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of High Static Magnetic Fields on Biological Activities and Iron Metabolism in MLO-Y4 Osteocyte-like Cells.
    Yang J; Zhang G; Li Q; Tang Q; Feng Y; Shang P; Zeng Y
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation.
    Marahleh A; Kitaura H; Ohori F; Kishikawa A; Ogawa S; Shen WR; Qi J; Noguchi T; Nara Y; Mizoguchi I
    Front Immunol; 2019; 10():2925. PubMed ID: 31921183
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beta-adrenergic signaling affect osteoclastogenesis via osteocytic MLO-Y4 cells' RANKL production.
    Yao Q; Liang H; Huang B; Xiang L; Wang T; Xiong Y; Yang B; Guo Y; Gong P
    Biochem Biophys Res Commun; 2017 Jul; 488(4):634-640. PubMed ID: 27823934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.